Skip to main content

Global Hepatitis B Vaccines Market Is Expected To Reach US$ 1.89 Bn In Terms Of Value By 2025

According to the latest market report published by Credence Research, Inc. “Hepatitis B Vaccines Market - Growth, Future Prospects and Competitive Analysis, 2017 - 2025” the global hepatitis B vaccines market was valued at US$ 1.39 Bn in 2016, and is expected to reach US$ 1.89 Bn by 2025, expanding at a CAGR of 3.5% from 2017 to 2025.
Browse the full report Hepatitis B Vaccines Market - Growth, Future Prospects and Competitive Analysis, 2017 – 2025 report at https://www.credenceresearch.com/report/hepatitis-b-vaccine-market
Market Insights
Hepatitis B is life threatening liver infection. Hepatitis B vaccines market is rapidly growing as it is effective in prevention of infection than any other treatment options. Some factors such as increased awareness of hepatitis B infection prevention, government initiatives in conduction of routine immunization program are contributing the market growth of hepatitis B vaccines globally. For the purpose of study, global hepatitis B vaccines market is segmented on the basis of type of vaccines composition such as mono and combination vaccines. It is observed that in the base year 2016, combination vaccines held largest market share due to factors such as more patient compliance, better disease control and lower chances of missing immunization are driving the growth of combination vaccines market globally. On the basis of end users age, the hepatitis B vaccines market is categorized into pediatric and adult hepatitis B vaccines. Currently, adult hepatitis B vaccines is the major revenue contributing segment as adults are at a high risk of developing hepatitis B infections due to renal disease and HIV infection which is influencing the market growth of adult hepatitis B vaccines globally. Hepatitis B vaccines market is currently dominated by North America due to factors such as extensive R&D activities, higher cost of vaccines and immunization program that are driving the market growth in North America. Asia Pacific is anticipated to show highest CAGR during forecast period due to increasing healthcare awareness and government initiatives in immunization program.
Market Competition Assessment:
The hepatitis B vaccines market is observed to be highly competitive and comprises large number of players. However, the market is currently dominated by few players such as Beijing Minhai Biotechnology, CSL Ltd, Dynavax Technologies, Emergent Biosolutions, GlaxoSmithKline Biologicals, Merck & Co, Inc, Novartis AG, Pfizer Inc., Sanofi  Pasteur, Serum Institute of India, Sinovac Biotech and other.
Key Market Movements:
  • Governments across the world have mandated the immunization of hepatitis B for travelers. Hepatitis B vaccine is included in government national immunization schedules in various countries. And increase in awareness of hepatitis B infection prevention is driving the growth of hepatitis B vaccines market worldwide.
  • Processes of vaccine development and approval is stringently regulated by the regulatory authorities, which may negatively impact the market growth of hepatitis B vaccines globally.
  • Hepatitis B vaccine requires cold storage condition, it increases the market price of vaccines.  This would hinder the market growth in some countries.
Labels:

Comments

Post a Comment

Popular posts from this blog

Leadless Cardiac Pacemakers Market Is Expected To Reach US$ 269.8 Mn By 2026

The latest market report published by Credence Research, Inc. “Global  Leadless Cardiac Pacemakers Market  - Growth, Future Prospects, Competitive Analysis, 2018 - 2026,” the global leadless cardiac pacemakers market is expected to reach from US$ 47.1 Mn in 2017 to US$ 269.8 Mn by 2026 expanding at a CAGR of 21.9% from 2018 to 2026. Browse the full report  Leadless Cardiac Pacemakers Market  - Growth, Future Prospects, Competitive Analysis, 2018 – 2026 report at   https://www.credenceresearch.com/report/leadless-cardiac-pacemakers-market Market Insights Atrial fibrillation is a medical condition in which irregular heartbeats can lead to clinical manifestations such as stroke, blood clot, and other heart complications. Many patients suffering with atrial fibrillation are under the wrong impression that it is not a serious medical condition eventually increasing the occurrence of heart failure by 5 folds. Leadless pacema...
Post a Comment
Read more

Organic Hair Care Products Market Is Expected To Reach USD 4,956.8 Million In 2022

The global market for  organic hair care market  products witness growth on the back of rising health awareness among the consumer and availability of the products on various distribution channels. In addition, availability of the products in convenient size and packaging is another factor contributing towards the market growth. But, due short shelf life of the organic products and higher prices are the major factors restraining the market growth. However, in future rising demand from the end user segment and increasing income of the emerging economies will be the two major factors which will drive growth. Browse full report at( Organic Hair Care Market - Size, Share, Growth, Trends and Segment Forecasts to 2022) :   https://www.credenceresearch.com/report/organic-hair-care-market By product type, shampoo segments accounts for more than 35% share of the pie in 2014. It is also projected to maintain its dominance during the forecast period. In 2014, salon pro...
Post a Comment
Read more

Hip Replacement Implants Market Expected to Exhibit Steady Growth during the Forecast Period

The latest market report published by Credence Research, Inc. “ Hip Replacement Implants Market  - Growth, Future Prospects, Competitive Analysis, 2018 - 2026,”  the global hip replacement implants market was valued at US$ 7,202.5 Mn in 2017 expanding at a CAGR of 3.6% from 2018 to 2026. Browse full report at  https://www.credenceresearch.com/report/hip-replacement-implants-market Market Insights The global hip replacement implants market is driven by growing number of hip arthroplasty throughout the globe, rising prevalence of osteoporosis, osteoarthritis and hip ailments leading to hip replacement surgeries. Growth in trauma and injuries have also boosted the number of hip arthroplasty in the recent years. Product innovation and continuous research and development to improve the hip systems and materials is the major driver in increased demand of hip replacement implants. Many studies have emphasized the benefits of replacement surgeries in reducing p...
Post a Comment
Read more